Emerging digital tools enable older adults with long-term conditions like diabetes and hypertension to monitor health metrics remotely, improving independence and care collaboration amid increasingly user-friendly platforms and real-time sharing capabilities. Digital tools are becoming increasingly useful for older adults…
Eli Lilly reports a 48% increase in revenue driven by its leading diabetes and obesity medicines, with international sales soaring and new pipeline drugs showing promising results, as it raises its full-year outlook. Eli Lilly posted another sharply higher quarter,…
Lobia, or white beans, are increasingly recognised for their role in stabilising blood sugar and supporting weight loss, offering a nutritious and affordable addition to a balanced diet, with proper preparation key to their benefits. White beans, known in India…
Emerging research indicates that the pungent jengkol bean might help support blood sugar control in people with diabetes. While early findings are promising, health experts emphasise moderation and further human trials before definitive claims can be made. Jengkol, a pungent…
Scientists have developed glucose-sensitive probiotic bacteria capable of adapting in the gut to manage diabetes, potentially offering an oral alternative to injections and implants. Engineered probiotic bacteria may one day offer a way to manage diabetes from the gut rather…
Emerging studies reveal that the enzyme cathepsin D may interfere with insulin signalling in the liver, potentially contributing to prediabetes and offering new avenues for treatment. A protein best known for helping cells break down waste may also be interfering…
Florida State University’s health and nursing teams are opening enrolment for LEADR, a pioneering 12-week programme combining group support, personalised coaching, and lifestyle interventions to help individuals with prediabetes and type 2 diabetes improve health and potentially achieve remission. Florida…
The landmark Look AHEAD trial reveals that despite achieving short-term weight loss and metabolic improvements, intensive lifestyle interventions do not necessarily translate into lowered cardiovascular events among adults with type 2 diabetes, challenging assumptions about weight reduction as a primary…
Pharmaceutical giant Eli Lilly has launched its first lawsuits against six US companies, aiming to curb illegal sales of its unapproved weight-loss and diabetes treatment, retatrutide, amid growing risks to consumer safety. Eli Lilly has begun legal action against six…
Sami Inkinen’s shift from tech to medicine led to Virta Health’s pioneering approach, combining nutrition science, remote monitoring, and personalised coaching to transform diabetes management and challenge traditional care models. Sami Inkinen built a career in technology before turning his…
